M. Frank Erasmus

Many Routes to an Antibody Heavy-Chain CDR3: Necessary, Yet Insufficient, for Specific Binding

Sara D’Angelo, Fortunato Ferrara, Leslie Naranjo et al. · Frontiers in Immunology · 2018 · 100 citations · Full text

Life Sciences, Immunology, Molecular Biology +14

Drug-like antibodies with high affinity, diversity and developability directly from next-generation antibody libraries

André A. Teixeira, M. Frank Erasmus, Sara D’Angelo et al. · mAbs · 2021 · 64 citations · Full text

Pharmacy, Biotechnology, Molecular Biology +17

A pandemic-enabled comparison of discovery platforms demonstrates a naive antibody library can match the best immune-sourced antibodies

Fortunato Ferrara, M. Frank Erasmus, Sara D’Angelo et al. · Nature Communications · 2022 · 37 citations · Full text

Pharmacy, Biotechnology, Immunology +17

Insights into next generation sequencing guided antibody selection strategies

M. Frank Erasmus, Fortunato Ferrara, Sara D’Angelo et al. · Scientific Reports · 2023 · 26 citations · Full text

Pharmacy, Molecular Biology, Drug Design +16

Simultaneous affinity maturation and developability enhancement using natural liability-free CDRs

André A. Teixeira, Sara D’Angelo, M. Frank Erasmus et al. · mAbs · 2022 · 25 citations · Full text

Pharmacy, Biotechnology, Molecular Biology +16